MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Lumos Pharma, Inc. - Common Stock (NQ:LUMO)

4.340 UNCHANGED
Last Price Updated: 4:00 PM EST, Dec 11, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Lumos Pharma, Inc. - Common Stock

< Previous 1 2 3 4 Next >
News headline image
Lumos Pharma Promotes Pisit “Duke” Pitukcheewanont, MD to Chief Medical Officer
From Lumos Pharma, Inc.
Via GlobeNewswire
News headline image
Lumos Pharma to Host Virtual Key Opinion Leader Webinar to Discuss Phase 2 OraGrowtH Trial Data and Treatment Potential of Oral LUM-201 for Pediatric Growth Hormone Deficiency
Webinar to be Held December 6, 2023 at 1:30pm EST 
From Lumos Pharma, Inc.
Via GlobeNewswire
News headline image
Lumos Pharma Announces Participation in the Piper Sandler 35th Annual Healthcare Conference in November
From Lumos Pharma, Inc.
Via GlobeNewswire
News headline image
What 7 Analyst Ratings Have To Say About Lumos Pharma ↗
 
Via Benzinga
News headline image
The Latest Analyst Ratings for Lumos Pharma ↗
 
Via Benzinga
News headline image
Why Toast Shares Are Trading Lower By Around 17%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗
Gainers Heart Test Laboratories, Inc. (NASDAQ: HSCS) shares climbed 96% to $0.2921 after falling over 7% on Tuesday. 
Via Benzinga
News headline image
Why Is Biomarin & BridgeBio Pharma Rival Lumos Pharma Stock Trading Higher Today? ↗
Lumos Pharma Inc (NASDAQ: LUMO) announced that topline results from its Phase 2 OraGrowtH210 dose-finding trial and its Phase 2 OraGrowtH212 Pharmacokinetic/Pharmacodynamic (PK/PD) trial met all... 
Via Benzinga
News headline image
Lumos Pharma: Q1 Earnings Insights ↗
 
Via Benzinga
News headline image
Roblox, Under Armour, GoPro, Nuvei And Other Big Stocks Moving Higher On Wednesday ↗
U.S. stocks traded mostly lower, with the Nasdaq Composite falling around 20 points on Wednesday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Topics Stocks
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Why American Public Education Shares Are Trading Higher By Around 21%; Here Are 20 Stocks Moving Premarket ↗
Gainers Heart Test Laboratories, Inc. (NASDAQ: HSCS) shares surged 332% to $0.6455 in pre-market trading after falling over 7% on Tuesday. 
Via Benzinga
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗
Pre-market stock movers are a hot topic on Wednesday and we're starting the morning with a breakdown of the biggest ones. 
Via InvestorPlace
News headline image
Lumos Pharma Reports Third Quarter 2023 Financial Results and Clinical Development Updates
From Lumos Pharma, Inc.
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
 
Via Benzinga
News headline image
Lumos Pharma Announces Topline Data from Phase 2 OraGrowtH210 and OraGrowtH212 Trials of LUM-201 in PGHD Met All Primary and Secondary Endpoints
Phase 2 Data Provide Supportive Evidence to Advance Oral LUM-201 to Phase 3 
From Lumos Pharma, Inc.
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Lumos Pharma Announces New Data and Analysis of 15 Subjects from OraGrowtH212 Trial Presented at the 2023 ESPE Annual Meeting
From Lumos Pharma, Inc.
Via GlobeNewswire
News headline image
Lumos Pharma Announced Abstract Accepted for Oral Presentation at the European Society for Paediatric Endocrinology Annual Meeting
From Lumos Pharma, Inc.
Via GlobeNewswire
News headline image
Lumos Pharma Announces Participation in Investor Conferences in September
From Lumos Pharma, Inc.
Via GlobeNewswire
News headline image
Independent Panel of Renowned Pediatric Endocrinologists to Discuss Pediatric Growth Hormone Deficiency and the Therapeutic Landscape
Virtual Webinar to be held September 5, 2023, at 11:00 AM Eastern Time 
From Lumos Pharma, Inc.
Via GlobeNewswire
News headline image
Lumos Pharma Reports Second Quarter 2023 Financial Results, Provides Clinical Update
From Lumos Pharma, Inc.
Via GlobeNewswire
News headline image
Lumos Pharma to Report Second Quarter 2023 Financial Results and Host Conference Call on August 9, 2023
From Lumos Pharma, Inc.
Via GlobeNewswire
News headline image
Lumos Pharma to Participate in the Oppenheimer 2023 Montauk Life Sciences Summit
From Lumos Pharma, Inc.
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
 
Via Benzinga
News headline image
Lumos Pharma Announces Departure of Chief Medical Officer
From Lumos Pharma, Inc.
Via GlobeNewswire
News headline image
Lumos to Highlight New LUM-201 Data and Analysis Presented at ENDO 2023 in Virtual KOL Webinar
From Lumos Pharma, Inc.
Via GlobeNewswire
News headline image
Lumos Pharma to Participate in the Upcoming 2023 BIO International Convention and the Jefferies Healthcare Conference
From Lumos Pharma, Inc.
Via GlobeNewswire
News headline image
Lumos Pharma Announces Abstracts Accepted for Oral Presentation at 2023 ENDO Meeting with Virtual KOL Event to be Held on June 21st
KOL Webinar to be held June 21, 2023 at 11:00 AM Eastern Time 
From Lumos Pharma, Inc.
Via GlobeNewswire
News headline image
Lumos Pharma to Participate in World Orphan Drug Congress USA
From Lumos Pharma, Inc.
Via GlobeNewswire
News headline image
Encouraging Data from Lumos Pharma OraGrowtH Trials Presented at Annual Pediatric Endocrine Society Meeting (PES)
From Lumos Pharma, Inc.
Via GlobeNewswire
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story